| The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization RM Canet-Avilés, MA Wilson, DW Miller, R Ahmad, C McLendon, ... Proceedings of the National Academy of Sciences 101 (24), 9103-9108, 2004 | 1382 | 2004 |
| The expression of DJ‐1 (PARK7) in normal human CNS and idiopathic Parkinson’s disease R Bandopadhyay, AE Kingsbury, MR Cookson, AR Reid, IM Evans, ... Brain 127 (2), 420-430, 2004 | 584 | 2004 |
| Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system R Betarbet, RM Canet-Aviles, TB Sherer, PG Mastroberardino, ... Neurobiology of disease 22 (2), 404-420, 2006 | 425 | 2006 |
| L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system PP Zhu, J Stadler, GR Klinefelter, C Blackstone, DW Miller, R Ahmad, ... Journal of Biological Chemistry 278 (38), 36588-36595, 2003 | 316 | 2003 |
| Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization J Blackinton, R Ahmad, DW Miller, MP Van Der Brug, RM Canet-Avilés, ... Molecular brain research 134 (1), 76-83, 2005 | 118 | 2005 |
| Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase Cα, src-tyrosine kinase and extracellular … RM Canet-Aviles, M Anderton, NM Hooper, AJ Turner, PFT Vaughan Molecular brain research 102 (1-2), 62-72, 2002 | 73 | 2002 |
| Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease O Libiger, LM Shaw, MH Watson, AC Nairn, KL Umaña, MC Biarnes, ... Alzheimer's & Dementia 17 (12), 1976-1987, 2021 | 62 | 2021 |
| Proceedings: cell therapies for Parkinson's disease from discovery to clinic R Canet-Aviles, GP Lomax, EG Feigal, C Priest Stem Cells Translational Medicine 3 (9), 979-991, 2014 | 12 | 2014 |
| Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, Longitudinal CSF Proteomics Project Team.(2021). Longitudinal CSF proteomics identifies NPTX2 as … O Libiger, LM Shaw, MH Watson, AC Nairn, KL Umaña, MC Biarnes, ... Alzheimer's & Dementia: The Journal of the Alzheimer's Association 17 (12 …, 0 | 10 | |
| Identification of NPTX2 as a prognostic biomarker of Alzheimer’s disease through a longitudinal CSF proteomics study in ADNI subjects: Developing topics O Libiger, LM Shaw, M Watson, AC Nairn, K Umaña, RM Canet‐Avilés, ... Alzheimer's & Dementia 16, e047605, 2020 | 2 | 2020 |
| Cell Therapies for Parkinson’s Disease From Discovery to Clinic R Canet-Aviles, GP Lomax, EG Feigal, C Priest Cell, 2014 | | 2014 |
| Challenges of Taking Embryonic Stem Cells from Bench to Clinic P Tekamp-Olson, RM Canet-Aviles, LR Collins, BJ Steffen, S Talib, ... Stem Cells: From Bench to Bedside, 185-208, 2011 | | 2011 |
| Cuadra, AE and El-Fakahany, EE Mechanisms of M1 muscarinic receptor-mediated up-regulation of neuronal nitric oxide synthase in N1E-115 neuroblastoma cells (134) 198 MJ Bailey, VM Cassone, J Blackinton, R Ahmad, DW Miller, ... Molecular Brain Research 134, 349-350, 2005 | | 2005 |
| PROTEIN SYNTHESIS, POST-TRANSLATION MODIFICATION, AND DEGRADATION-L166P Mutant D6J-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome … DW Miller, R Ahmad, S Hague, MJ Baptista, R Canet-Aviles, C McLendon, ... Journal of Biological Chemistry 278 (38), 36588-36595, 2003 | | 2003 |
| Regulation of soluble amyloid precursor protein (sAPP) alpha secretion by muscarine in the human neuroblastoma cell line SH-SY5Y RM Canet-Aviles, AJ Turner, NM Hooper, PF Vaughan BIOCHEMICAL SOCIETY TRANSACTIONS 28 (1), 33-33, 2000 | | 2000 |
